Rankings
▼
Calendar
NTLA Q4 2016 Earnings — Intellia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
NTLA
Intellia Therapeutics, Inc.
$2B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
Gross Profit
-$6M
-101.4% margin
Operating Income
-$11M
-192.3% margin
Net Income
-$11M
-187.7% margin
EPS (Diluted)
$-0.31
QoQ Revenue Growth
+15.6%
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$18M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$299M
Total Liabilities
$89M
Stockholders' Equity
$210M
Cash & Equivalents
$273M
← FY 2016
All Quarters
Q1 2017 →
